Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Joachim Haupt

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Briefings in Bioinformatics|March 29, 2011
Old friends in new guise: repositioning of known drugs with structural bioinformaticsV Joachim Haupt, Michael Schroeder
Plos One|June 28, 2013
Drug Promiscuity in PDB: Protein Binding Site Similarity Is KeyV Joachim Haupt, Simone Daminelli, Michael Schroeder
Current Topics in Medicinal Chemistry|June 12, 2010
Chemoinformatic analysis of biologically active macrocyclesWolfgang Brandt, V Joachim Haupt, Ludger A Wessjohann
Progress in Biophysics and Molecular Biology|June 14, 2014
Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessmentSebastian Salentin, V Joachim Haupt, Simone Daminelli, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|April 28, 2012
Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease networkSimone Daminelli, V Joachim Haupt, Matthias Reimann, et al.
Nucleic Acids Research|April 16, 2015
PLIP: fully automated protein-ligand interaction profilerSebastian Salentin, Sven Schreiber, V Joachim Haupt, et al.
Scientific Reports|June 6, 2023
An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffoldsPhilipp Schake, Klevia Dishnica, Florian Kaiser, et al.
Oncotarget|September 15, 2016
New HSP27 inhibitors efficiently suppress drug resistance development in cancer cellsJörg C Heinrich, Sainitin Donakonda, V Joachim Haupt, et al.
Computational and Structural Biotechnology Journal|July 21, 2021
Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitorSarah Naomi Bolz, Sebastian Salentin, Gary Jennings, et al.
Briefings in Bioinformatics|April 29, 2017
Pioneering topological methods for network-based drug-target prediction by exploiting a brain-network self-organization theoryClaudio Durán, Simone Daminelli, Josephine M Thomas, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Briefings in Bioinformatics|March 29, 2011
Old friends in new guise: repositioning of known drugs with structural bioinformaticsV Joachim Haupt, Michael Schroeder
Plos One|June 28, 2013
Drug Promiscuity in PDB: Protein Binding Site Similarity Is KeyV Joachim Haupt, Simone Daminelli, Michael Schroeder
Current Topics in Medicinal Chemistry|June 12, 2010
Chemoinformatic analysis of biologically active macrocyclesWolfgang Brandt, V Joachim Haupt, Ludger A Wessjohann
Progress in Biophysics and Molecular Biology|June 14, 2014
Polypharmacology rescored: protein-ligand interaction profiles for remote binding site similarity assessmentSebastian Salentin, V Joachim Haupt, Simone Daminelli, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|April 28, 2012
Drug repositioning through incomplete bi-cliques in an integrated drug-target-disease networkSimone Daminelli, V Joachim Haupt, Matthias Reimann, et al.
Nucleic Acids Research|April 16, 2015
PLIP: fully automated protein-ligand interaction profilerSebastian Salentin, Sven Schreiber, V Joachim Haupt, et al.
Scientific Reports|June 6, 2023
An interaction-based drug discovery screen explains known SARS-CoV-2 inhibitors and predicts new compound scaffoldsPhilipp Schake, Klevia Dishnica, Florian Kaiser, et al.
Oncotarget|September 15, 2016
New HSP27 inhibitors efficiently suppress drug resistance development in cancer cellsJörg C Heinrich, Sainitin Donakonda, V Joachim Haupt, et al.
Computational and Structural Biotechnology Journal|July 21, 2021
Structural binding site comparisons reveal Crizotinib as a novel LRRK2 inhibitorSarah Naomi Bolz, Sebastian Salentin, Gary Jennings, et al.
Briefings in Bioinformatics|April 29, 2017
Pioneering topological methods for network-based drug-target prediction by exploiting a brain-network self-organization theoryClaudio Durán, Simone Daminelli, Josephine M Thomas, et al.
Pageof 3